Biotech Values

[ghmm]

If it (IVIG) works what would other immunoglobulin makers need to do to get approved. Would they need full efficacy studies in the patient population? That would still give Baxter a pretty big head start (though capacity will be an issue).

Being long HALO I am biased but I thought this would be a great HyQ (sub-q) indication (which as a bonus would have IP too).